{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:06:57Z","timestamp":1789063617059,"version":"build-2803163510"},"reference-count":58,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"BE Life Sciences Pvt. Ltd."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/21645515.2026.2722480","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:21:57Z","timestamp":1789060917000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Immunogenicity and safety of inactivated TZ84- vs. HM175-based hepatitis A vaccines in pediatric populations: A systematic review and meta-analysis"],"prefix":"10.1080","volume":"22","author":[{"given":"Ritabrata","family":"Kundu","sequence":"first","affiliation":[{"name":"Institute of Child Health","place":["Kolkata, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurba","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Institute of Child Health","place":["Kolkata, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Toppo","sequence":"additional","affiliation":[{"name":"BE Life Sciences Pvt. Ltd.","place":["Hyderabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha Rani H.","family":"Patted","sequence":"additional","affiliation":[{"name":"BE Life Sciences Pvt. Ltd.","place":["Hyderabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2024.175473"},{"key":"e_1_3_5_3_1","volume-title":"Hepatitis A and other associated hepatobiliary diseases","author":"Chakravarti A","year":"2019","unstructured":"Chakravarti A, Bharara T. Epidemiology of hepatitis A: past and current trends. In: Streba CT, Vere CC, Rogoveanu I, Tripodi V, Lucangioli S, editors. Hepatitis A and other associated hepatobiliary diseases. London: IntechOpen; 2019. p. 1\u201317."},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10458-9"},{"key":"e_1_3_5_5_1","unstructured":"World Health Organization. Hepatitis A. 2025 [accessed 2025 Nov 6]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-a."},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28810"},{"key":"e_1_3_5_7_1","unstructured":"World Health Organization (WHO). The immunological basis for immunization series: module 18 - hepatitis A. 2019 [accessed 2025 Dec 3]. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/270c4dc5-cb11-47d9-bd00-069471541ca7\/content."},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13101900"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10232-4"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-024-10640-2"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12020204"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinmicnews.2020.10.001"},{"issue":"97","key":"e_1_3_5_13_1","first-page":"493","article-title":"WHO position paper on Hepatitis A vaccines \u2013 October 2022","volume":"40","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. WHO position paper on Hepatitis A vaccines \u2013 October 2022. Wkly Epidemiol Rec. 2022;40(97):493\u2013512.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15010214"},{"key":"e_1_3_5_15_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-3-030-77173-7_12","volume-title":"Pediatric vaccines and vaccinations: a European textbook","author":"Van Damme P","year":"2021","unstructured":"Van Damme P, Hendrickx G. Hepatitis A vaccines. In: Vesikari T, Van Damme P, editors. Pediatric vaccines and vaccinations: a European textbook. Switzerland: Springer Cham; 2021. p. 115\u2013125."},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.104"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.27124"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.06.004"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.11.005"},{"key":"e_1_3_5_20_1","unstructured":"WHO position paper on hepatitis A vaccines. WHO. 2012 [accessed 2025 Nov 6]. https:\/\/www.who.int\/publications\/i\/item\/who-wer8728-29-261-276."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.24366"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.28631"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2447643"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13050446"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.10.018"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-024-3104-5"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2227549"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(92)90557-Z"},{"key":"e_1_3_5_29_1","unstructured":"Summary of Product Characteristics. Biological E Limited. Inactivated hepatitis A vaccine. [accessed 2025 Nov 4]. https:\/\/Cdsco.Gov.in\/Opencms\/Resources\/UploadCDSCOWeb\/2018\/UploadSmPC\/10.SmPC%20-%20Hepatitis%20A%20Vaccine%20(Bio%20E.%20Ltd).Pdf."},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1715687"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1278329"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00264-12"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1197450"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-025-01996-8"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.08.078"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1134069"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.038"},{"key":"e_1_3_5_39_1","unstructured":"World Health Organization. WHO expert committee on Biological standardization sixty-seventh report. Annex 9. Guidelines on clinical evaluation of vaccines: regulatory expectations. https:\/\/cdn.who.int\/media\/docs\/default-source\/prequal\/vaccines\/who-trs-1004-web-annex-9.pdf."},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12090969"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6806a6"},{"key":"e_1_3_5_42_1","unstructured":"World Health Organization. Immunization vaccines and biologicals. Vaccines for hepatitis A B and E. [accessed 2025 Nov 6]. https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/diseases\/hepatitis."},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.672221"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.08.037"},{"issue":"10","key":"e_1_3_5_45_1","first-page":"1483","article-title":"Immunogenicity and safety of a new inactivated hepatitis A vaccine in young adults: a comparative study","volume":"115","author":"Ren A","year":"2002","unstructured":"Ren A, Feng F, Ma J, Xu Y, Liu C. Immunogenicity and safety of a new inactivated hepatitis A vaccine in young adults: a comparative study. Chin Med J (Engl). 2002;115(10):1483\u20131485.","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"e_1_3_5_46_1","first-page":"1013","article-title":"The study on the 0, 12 month vaccination schedule\u2019of Healive inactivated hepatitis A vaccine in children","volume":"24","author":"Ren YH","year":"2003","unstructured":"Ren YH, Chen JT, Wu WT, Gong X-J, Zhang Y-C, Xue W-H, Ren Y-F, Han L-J, Kang W-X, Li S-P, et al. The study on the 0, 12 month vaccination schedule\u2019of Healive inactivated hepatitis A vaccine in children. Zhonghua Liu Xing Bing Xue Za Zhi. 2003;24(11):1013\u20131015.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199208133270702"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510410040030"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_636_17"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.2771"},{"issue":"14","key":"e_1_3_5_51_1","first-page":"955","article-title":"Effectiveness of post-exposure prophylaxis using live attenuated hepatitis alpha vaccine (H (2) strain) among schoolchildren","volume":"82","author":"Wang X","year":"2002","unstructured":"Wang X, Ma J, Xu Z, Liu H, Zhang Y, Han C. Effectiveness of post-exposure prophylaxis using live attenuated hepatitis alpha vaccine (H (2) strain) among schoolchildren. Zhonghua Yi Xue Za Zhi. 2002;82(14):955\u2013957.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.11.008"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.008"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00311-8"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.230417497"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.036"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1819742"},{"key":"e_1_3_5_58_1","unstructured":"Centers for Disease Control and Prevention. Hepatitis A vaccine administration. https:\/\/www.cdc.gov\/hepatitis-a\/hcp\/vaccine-administration\/index.html."},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.21909"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2722480","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2026.2722480","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2722480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:22:00Z","timestamp":1789060920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2026.2722480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/21645515.2026.2722480"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2026.2722480","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2722480"}}